EUVIMEDEUVIMED entdecken
Crossref

Targeting the TGF-β pathway in patients with non-small cell lung cancer

Markus Joerger

AME Clinical Trials Review · 2024-10 · 2 · 76-76

DOI: 10.21037/actr-24-80 ↗

Kurz gefasst

Fachartikel in der Zeitschrift AME Clinical Trials Review, 2024-10. Verfasst von Markus Joerger. Die Arbeit wurde bisher 4-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Joerger, M. (2024). Targeting the TGF-β pathway in patients with non-small cell lung cancer. AME Clinical Trials Review, 2, 76-76. https://doi.org/10.21037/actr-24-80

Vancouver

Joerger M. Targeting the TGF-β pathway in patients with non-small cell lung cancer. AME Clinical Trials Review. 2024;2:76-76. doi:10.21037/actr-24-80

BibTeX
@article{Joerger2024,
  author = {Joerger, Markus},
  title = {Targeting the TGF-β pathway in patients with non-small cell lung cancer},
  journal = {AME Clinical Trials Review},
  year = {2024},
  volume = {2},
  pages = {76--76},
  doi = {10.21037/actr-24-80}
}
Kostenlos starten →